Atherogenic modified LDL in diabetes

被引:34
作者
Sobenin, IA
Tertov, VV
Orekhov, AN
机构
关键词
D O I
10.2337/diab.45.3.S35
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This paper summarizes the recent findings on LDL atherogenic modifications in diabetic patients. LDL from diabetic patients, unlike LDL from healthy subjects, caused a significant increase in cholesterol content of cells cultured hom unaffected human aortic intima, i.e., produced a direct atherogenic effect. LDL was divided into two fractions (nonbound and bound) by affinity chromatography on Ricinus communis agglutinin-agarose. The amount of bound LDL was significantly higher in diabetic patients compared with healthy subjects. Bound LDL was characterized by significantly lowered sialic acid content and a significantly increased fructosyl lysine level compared with unbound LDL, i.e., was desialylated and nonenzymatically glycosylated lipoprotein. The bound (desialylated), but not unbound (sialylated), EDL subfraction induced cholesterol accumulation in cultured cells. Bound LDL was also characterized by a significantly lowered content of neutral lipids and demonstrated increased electrophoretic mobility on agarose gel electrophoresis. Bound and nonbound LDL differed significantly in hydrated density and particle size, as was determined by density gradient ultracentrifugation and native polyacrylamide gradient gel electrophoresis. The results of this study have shown that the in vivo modified atherogenic LDL subfraction in the blood of diabetic patients is represented by small, dense, more electronegative, desialylated, and glycated LDL.
引用
收藏
页码:S35 / S39
页数:5
相关论文
共 64 条
[31]  
MUSLINER TA, 1988, CLIN CHEM, V34, pB78
[32]   BLOOD-SERUM ATHEROGENICITY ASSOCIATED WITH CORONARY ATHEROSCLEROSIS - EVIDENCE FOR NONLIPID FACTOR PROVIDING ATHEROGENICITY OF LOW-DENSITY LIPOPROTEINS AND AN APPROACH TO ITS ELIMINATION [J].
OREKHOV, AN ;
TERTOV, VV ;
POKROVSKY, SN ;
ADAMOVA, IY ;
MARTSENYUK, ON ;
LYAKISHEV, AA ;
SMIRNOV, VN .
CIRCULATION RESEARCH, 1988, 62 (03) :421-429
[33]  
OREKHOV AN, 1992, J LIPID RES, V33, P805
[34]   MODIFICATION OF LOW-DENSITY LIPOPROTEIN BY DESIALYLATION CAUSES LIPID-ACCUMULATION IN CULTURED-CELLS - DISCOVERY OF DESIALYLATED LIPOPROTEIN WITH ALTERED CELLULAR-METABOLISM IN THE BLOOD OF ATHEROSCLEROTIC PATIENTS [J].
OREKHOV, AN ;
TERTOV, VV ;
MUKHIN, DN ;
MIKHAILENKO, IA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 162 (01) :206-211
[35]   DESIALYLATED LOW-DENSITY-LIPOPROTEIN - NATURALLY-OCCURRING MODIFIED LIPOPROTEIN WITH ATHEROGENIC POTENCY [J].
OREKHOV, AN ;
TERTOV, VV ;
MUKHIN, DN .
ATHEROSCLEROSIS, 1991, 86 (2-3) :153-161
[36]   TRIGGER-LIKE STIMULATION OF CHOLESTEROL ACCUMULATION AND DNA AND EXTRACELLULAR-MATRIX SYNTHESIS INDUCED BY ATHEROGENIC SERUM OR LOW-DENSITY LIPOPROTEIN IN CULTURED-CELLS [J].
OREKHOV, AN ;
TERTOV, VV ;
KUDRYASHOV, SA ;
SMIRNOV, VN .
CIRCULATION RESEARCH, 1990, 66 (02) :311-320
[37]   LIPIDS IN CELLS OF ATHEROSCLEROTIC AND UNINVOLVED HUMAN AORTA .2. LIPID-METABOLISM IN PRIMARY CULTURE [J].
OREKHOV, AN ;
TERTOV, VV ;
SMIRNOV, VN .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1985, 43 (02) :187-195
[38]   LIPIDS IN CELLS OF ATHEROSCLEROTIC AND UNINVOLVED HUMAN AORTA .1. LIPID-COMPOSITION OF AORTIC TISSUE AND ENZYME-ISOLATED AND CULTURED-CELLS [J].
OREKHOV, AN ;
TERTOV, VV ;
NOVIKOV, ID ;
KRUSHINSKY, AV ;
ANDREEVA, ER ;
LANKIN, VZ ;
SMIRNOV, VN .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1985, 42 (01) :117-137
[39]  
OREKHOV AN, 1986, AM J PATHOL, V125, P402
[40]  
OREKHOV AN, 1984, ACTA ANAT, V119, P99